Error parsing IP fragment: unable to parse character reference ' Conditions in https://www.whocc.no/use_of_atc_ddd/'' (last text = '
' at line 8 column 272
Canadian Baseline, published by HL7 Canada - FHIR Implementation Work Group. This guide is not an authorized publication; it is the continuous build for version 1.2.0 built by the FHIR (HL7® FHIR® Standard) CI Build. This version is based on the current content of https://github.com/HL7-Canada/ca-baseline/ and changes regularly. See the Directory of published versions ( src
)
If the service identified by the ServiceRequest.category is laboratory procedure the pan-Canadian LOINC Observation Code Database (pCLOCD) is preferred. pCLOCD is the Canadian version of the LOINC(tm) database. ( src
)
TBD. This is a placeholder for a comprehensive valueset, consisting of all Manufactured Product (MP), Non-proprietary Therapeutic Product (NTP) and Therapeutic Moiety (TM) codes, which would be created and maintained by Canada Health Infoway. Medicinal products for prescribing and dispensing in Canada. The content of this subset only contains commonly used medicinal products that are available for prescribing and dispensing in Canada. This content will expand to include all human medicinal products over time. ( src
)
The pan-Canadian LOINC Observation Code Database (pCLOCD) is the Canadian version of the LOINC(tm) database. It was created using the LOINC(tm) records and attributes that were constrained for Canadian use and supplemented to specifically meet Canadian requirements. It contains the core LOINC(tm) attributes as required by Regenstrief copyright rules. The LOINC(tm) Component has been customized to meet Canadian requirements and is displayed as the pan Canadian Component Name. This component name is the basis for the pan Canadian Display Name. Core attributes are include both English and Canadian French. ( src
)
There are examples where a medication request may include the option of an oral dose or an Intravenous or Intramuscular dose. For example, "Ondansetron 8mg orally or IV twice a day as needed for nausea" or "Compazine® (prochlorperazine) 5-10mg PO or 25mg PR bid prn nausea or vomiting". In these cases, two medication requests would be created that could be grouped together. The decision on which dose and route of administration to use is based on the patient's condition at the time the dose is needed. ( src
)
This publication may include content used under license. Some content (for example, LOINC,® SNOMED CT, or CPT® terminologies) may be included which may require separate licensing for depending on use, such as implementation. Directly review any third-party licensing terms to ensure they permit your intended use. ( src
)
Value of extension Binding: EthnicityCode (preferred): One of self-reported ethnic group codes representing the ethnicity concept and should not be confused with citizenship or nationality. Example Example of the Ethnicity extension: {"system":"http://snomed.info/sct","code":"733446001","display":"Canadian (ethnic group)"}
Code for the specific non-drug allergen Binding:
NonDrugAllergenCode (preferred): Represents the specific non-drug allergen or other agent/substance to which the Client has an allergic reaction.
Medicinal products for prescribing Binding:
PrescriptionMedicinalProduct (20260815) (preferred): Represents subset of codes with commonly used medicinal products that are available for prescribing and dispensing in Canada.
How the subject was exposed to the substance Binding:
RouteOfAdministration (preferred): A coded concept describing the route or physiological path of administration of a therapeutic agent into or onto the body of a subject.
Codes that identify this medication Binding:
PrescriptionMedicinalProduct (20260815) (preferred): TBD. This is a placeholder for a comprehensive valueset, consisting of all Manufactured Product (MP), Non-proprietary Therapeutic Product (NTP) and Therapeutic Moiety (TM) codes, which would be created and maintained by Canada Health Infoway. Medicinal products for prescribing and dispensing in Canada. The content of this subset only contains commonly used medicinal products that are available for prescribing and dispensing in Canada. This content will expand to include all human medicinal products over time. Example DIN: {"coding":[{"system":"http://terminology.hl7.org/NamingSystem/ca-hc-din","code":"02422921"}]} Example NPN: {"coding":[{"system":"http://terminology.hl7.org/CodeSystem/v3-hc-npn","code":"80075245"}]} Example CCDD: {"coding":[{"system":"http://terminology.hl7.org/CodeSystem/hc-CCDD","code":"02362783"}]} Example SNOMED CT (Medications) - IPS: {"coding":[{"system":"http://snomed.info/sct","code":"69008"}]} Example WHO ATC IPS: {"coding":[{"system":"http://www.whocc.no/atc","code":"A01AA01"}]}
powder | tablets | capsule + Binding:
DispensableDrugForm (example): TBD. This is a placeholder for a comprehensive valueset, which would be created and maintained by Canada Health Infoway. Currently seeking implementer feedback and input from pan-Canadian profiles to support updates to the nominated valueSet.
What was administered Binding:
PrescriptionMedicinalProduct (20260815) (preferred): TBD. This is a placeholder for a comprehensive valueset, consisting of all Manufactured Product (MP), Non-proprietary Therapeutic Product (NTP) and Therapeutic Moiety (TM) codes, which would be created and maintained by Canada Health Infoway. Medicinal products for prescribing and dispensing in Canada. The content of this subset only contains commonly used medicinal products that are available for prescribing and dispensing in Canada. This content will expand to include all human medicinal products over time.
What medication was supplied Binding:
PrescriptionMedicinalProduct (20260815) (preferred): TBD. This is a placeholder for a comprehensive valueset, consisting of all Manufactured Product (MP), Non-proprietary Therapeutic Product (NTP) and Therapeutic Moiety (TM) codes, which would be created and maintained by Canada Health Infoway. Medicinal products for prescribing and dispensing in Canada. The content of this subset only contains commonly used medicinal products that are available for prescribing and dispensing in Canada. This content will expand to include all human medicinal products over time. Example DIN: {"coding":[{"system":"http://terminology.hl7.org/NamingSystem/ca-hc-din","code":"02422921"}]} Example NPN: {"coding":[{"system":"http://terminology.hl7.org/CodeSystem/v3-hc-npn","code":"80075245"}]} Example CCDD: {"coding":[{"system":"http://terminology.hl7.org/CodeSystem/hc-CCDD","code":"02362783"}]} Example SNOMED CT (Medications) - IPS: {"coding":[{"system":"http://snomed.info/sct","code":"69008"}]} Example WHO ATC IPS: {"coding":[{"system":"http://www.whocc.no/atc","code":"A01AA01"}]}
Medication to be taken Binding:
PrescriptionMedicinalProduct (20260815) (preferred): TBD. This is a placeholder for a comprehensive valueset, consisting of all Manufactured Product (MP), Non-proprietary Therapeutic Product (NTP) and Therapeutic Moiety (TM) codes, which would be created and maintained by Canada Health Infoway. Medicinal products for prescribing and dispensing in Canada. The content of this subset only contains commonly used medicinal products that are available for prescribing and dispensing in Canada. This content will expand to include all human medicinal products over time.
What medication was taken Binding:
PrescriptionMedicinalProduct (20260815) (preferred): TBD. This is a placeholder for a comprehensive valueset, consisting of all Manufactured Product (MP), Non-proprietary Therapeutic Product (NTP) and Therapeutic Moiety (TM) codes, which would be created and maintained by Canada Health Infoway. Medicinal products for prescribing and dispensing in Canada. The content of this subset only contains commonly used medicinal products that are available for prescribing and dispensing in Canada. This content will expand to include all human medicinal products over time.
Laboratory procedure code Binding: https://fhir.infoway-inforoute.ca/ValueSet/pCLOCD (preferred): The pan-Canadian LOINC Observation Code Database (pCLOCD) is the Canadian version of the LOINC(tm) database. It was created using the LOINC(tm) records and attributes that were constrained for Canadian use and supplemented to specifically meet Canadian requirements. It contains the core LOINC(tm) attributes as required by Regenstrief copyright rules. The LOINC(tm) Component has been customized to meet Canadian requirements and is displayed as the pan Canadian Component Name. This component name is the basis for the pan Canadian Display Name. Core attributes are include both English and Canadian French.
Canadian Baseline, published by HL7 Canada - FHIR Implementation Work Group. This guide is not an authorized publication; it is the continuous build for version 1.2.0 built by the FHIR (HL7® FHIR® Standard) CI Build. This version is based on the current content of https://github.com/HL7-Canada/ca-baseline/
and changes regularly. See the Directory of published versions
The codes SHOULD be taken from For example codes, see
PharmaceuticalBiologicProductAndSubstanceCode http://hl7.org/fhir/ValueSet/allergyintolerance-code|4.0.1
( preferred
to https://fhir.infoway-inforoute.ca/ValueSet/pharmaceuticalbiologicproductandsubstancecode
)
The identification of the specific substance (or pharmaceutical product) considered to be responsible for the Adverse Reaction event uses Substance Code value set with Example
binding.
Consider use Canadian Clinical Drug Data
set in case of medication allergy/intolerance, and SNOMED CT for other substances/agents.
The codes SHOULD be taken from For example codes, see
HealthConditionCode http://hl7.org/fhir/ValueSet/condition-code|4.0.1
( preferred
to https://fhir.infoway-inforoute.ca/ValueSet/healthconditioncode
)
The Condition.code
element is CodeableConcept
data type meaning that more than one Coding
sub-elements can be present.
One of these Coding sub-elements SHALL use Health Concern Code
value set from Canada Health Infoway. Other Coding component are transaltion of the HealthConcernCode to other code systems.
The codes SHOULD be taken from For example codes, see https://cvc.canimmunize.ca/v3/ValueSet/Diseasehttp://hl7.org/fhir/ValueSet/immunization-recommendation-target-disease|4.0.1
( preferred
to https://cvc.canimmunize.ca/v3/ValueSet/Disease
)
The codes SHOULD be taken from For example codes, see
PrescriptionMedicinalProduct (20260815) http://hl7.org/fhir/ValueSet/medication-codes|4.0.1
( preferred
to https://fhir.infoway-inforoute.ca/ValueSet/prescriptionmedicinalproduct
)
For example codes, see
DispensableDrugForm http://hl7.org/fhir/ValueSet/medication-form-codes|4.0.1
( example
to https://fhir.infoway-inforoute.ca/ValueSet/dispensabledrugform
)
This profile was generated from HL7 StructureDefinition
on 2019-03-28 and constrained during a review of US Core against Canadian sources. RxNorm is not used in Canada and the list of medicinal products available differs from the US, therefore PrescribeIT Medication Profile
was used as a basis for this profile - with some significant differences due to structural differences between versions of FHIR.
The full list of identifiers can be found on Canadian URI Registry
. Canada Health Infoway provides Canadian URI Registry search tool
to simplify search.
Qualification defines a code for the degree or educational rank that the credential specifies and may also apply to an expertise type.
This profile recommends to use Canadian QualifiedRoleType
value set as the coded representation of the provider's qualification.
Credential defines a role type that is used to categorize an entity that delivers health care in an expected and professional manner to an entity in need of health care services.
It uses Canadian HealthcareProviderRoleType
value set as the coded representation of the provider's credentials.
This profile recommends to use Canadian QualifiedRoleType
value set as the coded representation of the provider's qualification.
This value set lists codes for the degree or educational rank that the credential specifies. It may also apply to an Expertise type.
Roles which this practitioner is authorized to perform for the organization are defined by Canadian HealthcareProviderRoleType
value set as the coded representation of the provider's credentials.
Credential defines a role type that is used to categorize an entity that delivers health care in an expected and professional manner to an entity in need of health care services.
Specific specialty of the practitioner defines the clinical, medical, surgical or other healthcare-related service specialty of a practitioner who interacts, treats or provides such services to or for a patient.
This profile recommends to use Canadian PractitionerSpecialty
value set for speciality codes.
The codes SHOULD be taken from For example codes, see
ProcedureCode http://hl7.org/fhir/ValueSet/procedure-code|4.0.1
( preferred
to https://fhir.infoway-inforoute.ca/ValueSet/procedurecode
)
If the service identified by the ServiceRequest.category
is laboratory procedure
the pan-Canadian LOINC Observation Code Database
( pCLOCD
) is preferred. pCLOCD is the Canadian version of the LOINC(tm) database.
The scope of this subset is passive immunizing agents that are currently licensed for use in Canada and those obtained through special access programs. The subset includes concepts represented by the trade name (brand name) of the passive immunizing agent (immune globulin or antitoxin) that was administered to the client. Passive immunizing agents are used to facilitate protection against vaccine preventable infections, when vaccines are not available or are contraindicated or when vaccines have not been used before exposure to the infective agent. This content is intended to be used when populating a record at the point of administration. Reviewers should anticipate that the representation of this valueSet will continue to evolve. This resource is an informative value set; a normative subset containing the expanded values can be found on Canada Health Infoway's Terminology Server
.
The scope of this subset is passive immunizing agents used in Canada (generically described, i.e. without trade name), those obtained through special access programs (generically described), and agents that have been discontinued and/or never licensed in Canada (with trade name). This content is intended to be used when populating an immunization history when the client and/or provider does not have the detail of the trade name of the agent administered OR the product has been discontinued and/or never licensed in Canada. Passive immunizing agents are used to facilitate protection against vaccine preventable infections, when vaccines are not available or are countraindicated or when vaccines have not been used before exposure to the infective agent. This subset will include concepts represented by a generic description for an agent that was previously administered to the client as may be expressed by the client or provider for an immunization history and concepts represented by the trade name for products that have been discontinued and/or never licensed in Canada. This resource is an informative value set; a normative subset containing the expanded values can be found on Canada Health Infoway's Terminology Server
. Reviewers should anticipate that the representation of this valueSet will continue to evolve
The scope of this subset is vaccines that are currently licensed for use in Canada and those obtained through special access programs for use in Canada. The subset includes concepts represented by the trade name (brand name) of the vaccine administered to the client. This content is intended to be used when populating a record at the point of immunization. This resource is an informative value set; a normative subset containing the expanded values can be found on Canada Health Infoway's Terminology Server
. Reviewers should anticipate that the representation of this valueSet will continue to evolve
The scope of this subset is vaccines that are currently licensed for use in Canada (generic description, i.e. no trade name), those obtained through special access programs (generic description), and vaccines that have been discontinued and/or never licensed in Canada (with trade name). This content is intended to be used when populating an immunization history when the client and /or provider does not have the detail of the trade name (brand name) of the vaccine administered OR the product has been discontinued and/or never licensed in Canada. This subset will include concepts represented by a generic description for a vaccine that was previously administered to the client as may be expressed by the client or provider for an immunization history and concepts represented by the trade name for products that have been discontinued and/or never licensed in Canada. This resource is an informative value set; a normative subset containing the expanded values can be found on Canada Health Infoway's Terminology Server
. Reviewers should anticipate that the representation of this valueSet will continue to evolve
The CA FHIR Baseline is a community developed specification that was made possible through the efforts and dedication of so many in our Canadian FHIR Implementer community
. The true list exceeds what we've been able to capture and is expected to grow as our community reviews and refines it.
(
preferred
)
